Author:
Wang Liang,Zhu Jie,Chen Liang,Du Hong
Subject
Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology
Reference87 articles.
1. Long-term compassionate use of cefiderocol to treat chronic osteomyelitis caused by extensively drug-resistant pseudomonas aeruginosa and extended-spectrum-β-lactamase-producing klebsiella pneumoniae in a pediatric patient;Alamarat;Antimicrob. Agents Chemother.,2020
2. Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship;Aoki;Eur. J. Med Chem.,2018
3. AST News Updates, 2023. Clinical & Laboratory Standards Institute. URL https://clsi.org/ast-news-updates-new/.
4. Proteomic and transcriptomic analyses indicate reduced biofilm-forming abilities in cefiderocol-resistant Klebsiella pneumoniae;Bao;Front. Microbiol.,2022
5. Designing A pathogen-focused study to address the high unmet medical need represented by carbapenem-resistant gram-negative pathogens - the international, multicenter, randomized, open-label, phase 3 CREDIBLE-CR study;Bassetti;Infect. Drug Resist,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献